To obtain a quantitative measure of the effect of treatment on histopathology, sections of both hind paws of all mice were scored for the severity of joint damage, extent of inflammation and bone erosion using an arbitrary scale by independent investigators 'blinded' to mouse identity.
However, markers of tissue damage characteristic of inflammation, apoptosis and ROS (reactive oxygen species) generation have been found in tissues of human and transgenic mouse models carriers of mutant TTR variants, well before amyloid deposits can be detected [ 8– 10].
This indicates that vertebral fractures can be seen as bony damage of rheumatoid inflammation and may be prevented by optimal disease activity suppression.
Photodynamic therapy was initially considered to be primarily a local treatment that caused direct tumour destruction via ROS and indirect tumour damage through vascular damage and induction of inflammation (Oleinick and Evans, 1998; Henderson and Gollnick, 2003).
NLRs (NOD-like receptors) and the structures that they form (inflammasomes) have been identified as sensors of cellular damage, including pressure induced damage, and triggers of inflammation.
APPs levels are reported to be directly related to severity of both tissue damage and level of inflammation, i.e. they are specific markers for tissue damage and inflammation [ 25].
As inflammation is a major driver of damage, an absence of inflammation a priori is a prerequisite for halting progression, and for making possible reversal of damage.
For instance, the ability of HS from lung epithelial cells to inhibit elastase activity may contribute to the normal control of tissue damage at sites of inflammation where neutrophil elastase has been shown to be involved.
As such, the magnitude of damage or inflammation of these structures is often associated with higher symptom levels.
These species are antibacterial agents, but misplaced or excessive production is implicated in tissue damage at sites of inflammation.
